Douglas G. Cole - Insider Trading & Ownership

Entity
Individual
Location
Aveo Pharmaceuticals, Inc., 75 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Douglas G. Cole is at least $578K dollars as of June 28, 2024. Douglas G. Cole is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $489K. Douglas G. Cole is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $88.3K.
All Insider Reports
All Insider Reports

Ownership of Douglas G. Cole

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $489K Jun 1, 2023
FHTX Foghorn Therapeutics Inc. Director $88.3K Jun 26, 2024
SANA Sana Biotechnology, Inc. Director Jun 6, 2024
SGTX Sigilon Therapeutics, Inc. Director Aug 11, 2023

Insider Transactions Reported by Douglas G. Cole:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.